Project Grant R01CA295673
Award Date 9/24/25
Completion Date 8/31/29
Dollars Obligated $3.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Virginia, USA
Similar Awards
- This federal Project Grant award, totaling $696,140, was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The grant aims to test a digital psychoeducation-activation tool and implementation strategy, called ICAN DEPCARE, to improve uptake of evidence-based depression treatment among cancer patients. The project, led by The Trustees of Columbia University in the City of New York, will conduct a clinic-level cluster randomized...
- The Project Grant award of $403,822, awarded by the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research), will fund a pilot study to develop and test the "DESCANSO" cognitive behavioral therapy (CBT) intervention to treat the symptom cluster of depression, insomnia, and fatigue in Spanish-speaking Latino cancer patients. The study aims to culturally adapt the DESCANSO intervention, which combines CBT strategies to address insomnia, depression, and...
- The National Cancer Institute (NCI), part of the U.S. Department of Health and Human Services, awarded a $1,338,648 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to the University of Pittsburgh. The grant will fund a "Hybrid Type I Cluster Randomized Effectiveness-Implementation Trial of CARES" to address clinically significant levels of depression, pain, and fatigue experienced by over 18 million Americans living with cancer. The project aims to...
- The U.S. Department of Health and Human Services, National Institutes of Health (NIH) awarded a $406,080 Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. The purpose of this 5-year grant, awarded on April 1, 2025, is to develop and test a novel daily, digital mindfulness-based intervention to reduce depressive symptoms in post-treatment cancer patients. The project will first create the...
- This Project Grant award of $2,746,080, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), supports research on the effects of remotely-delivered cognitive behavioral stress management (R-CBSM) on cancer-accelerated aging in older, distressed breast cancer survivors. The project will enroll 192 breast cancer survivors within 3-12 months of completing initial treatment, some of whom received chemotherapy. Participants will undergo...
- This NCI Early K99/R00 Project Grant from the National Cancer Institute's (NCI) Cancer Research Manpower (CFDA 93.398) program aims to refine and test the delivery of cognitive behavioral therapy for insomnia (CBT-I) to address insomnia and related symptoms in lung cancer survivors (LCS). The $224,968 award will fund a two-phase project. In the K99 phase, the grantee, Wake Forest University Health Sciences, will conduct stakeholder interviews and convene an advisory board to refine the CBT-I...
- The federal Project Grant award R34AT012767, provided by the National Center for Complementary and Integrative Health (NCCIH) under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), will fund feasibility and acceptability testing of an integrated intervention combining digital cognitive behavioral therapy for insomnia (dCBT-I) and passive body heating (PBH) for the treatment of insomnia disorder. The $737,480 award will support two studies: (1) an iterative...
- This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will provide $402,401 to the University of Missouri System to conduct a pilot study on the feasibility and impact of a metacognitive strategy training (MCST) intervention for women with cancer-related cognitive impairment (CRCI) following breast cancer treatment. The study aims to examine the effects of MCST on cognitive performance, frontoparietal neural functioning, and functional...
- This federal Project Grant award, valued at $682,272.00, was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The award will fund a research project entitled "Assessing Feasibility and Acceptability of a Multifaceted EHR-Integrated Mobile Health Intervention Following Radical Cystectomy" at the University of Michigan. The goal of the project is to develop and evaluate a novel, technology-enabled intervention to reduce...
- The National Cancer Institute (NCI) awarded a $404,295 Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) to Media REZ LLC (doing business as Daniel Greenberg & Associates) on September 8, 2025. This multi-phase project aims to develop and assess a patient-centered, patient-driven virtual reality (VR) intervention to improve the management of chronic cancer pain. Specifically, the project will: 1) Identify patient perceptions around chronic cancer pain...